Ultrasound to Enhance Paclitaxel Uptake in Critical Limb Ischemia: the PACUS Trial
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The PACUS Trial was a single center, single blinded, randomized trial designed to evaluate
the safety and efficacy of intravascular percutaneous catheter-delivered ultrasound energy to
improve local Paclitaxel delivery effects in critical limb ischemia patients due to
femoral-popliteal artery disease.